- Home
- NKTR vs SIBN Comparison
NKTR vs SIBN Comparison
Compare NKTR & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | SIBN |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 576.4M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NKTR | SIBN |
|---|---|---|
| Price | $75.00 | $12.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $142.00 | $24.13 |
| AVG Volume (30 Days) | ★ 825.7K | 526.1K |
| Earning Date | 06-10-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | $67,301,000.00 |
| Revenue This Year | N/A | $16.89 |
| Revenue Next Year | N/A | $14.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 86.00 | 21.53 |
| 52 Week Low | $0.43 | $12.50 |
| 52 Week High | $77.00 | $21.89 |
Technical Indicators
Market Signals| Indicator | NKTR | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 65.32 | 31.20 |
| Support Level | $52.99 | N/A |
| Resistance Level | $75.44 | $17.05 |
| Average True Range (ATR) | 3.99 | 0.72 |
| MACD | -0.64 | -0.13 |
| Stochastic Oscillator | 84.72 | 4.21 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.